Research map: The promising role of engineered T lymphocytes in immunotherapy for high-grade serous ovarian carcinoma: a review of mechanisms, clinical landscape, and future strategies

Back to the article

Papers in this map

  1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries · Freddie Bray · 2024 · 26051 citations · Cited by this paper
  2. MSA U-Net: a multi-scale attention-enhanced network for automatic segmentation of uterine lymph nodes in MRI images · 2026 · Related
  3. CRISPR-engineered T cells in patients with refractory cancer · Edward Allen Stadtmauer · 2020 · 1512 citations · Cited by this paper
  4. Lessons learned from different prognostic factors analysis in intermediate-risk neuroblastoma: ten years’ experience at a tertiary center · 2025 · Related
  5. Neoantigens: promising targets for cancer therapy · Na Xie · 2023 · 1004 citations · Cited by this paper
  6. Positive rates of endometrial and cervical cytology in ovarian cancer patients with BRCA1/2 germline pathogenic variants · 2026 · Related
  7. Recent advances and discoveries in the mechanisms and functions of CAR T cells · Rebecca C. Larson · 2021 · 881 citations · Cited by this paper
  8. A case–control study investigating the impact of gradient pressure therapy on chemotherapy-induced peripheral neuropathy symptoms and daily activities in paclitaxel-treated patients · 2025 · Related
  9. Tumor infiltrating lymphocytes in ovarian cancer · Phillip P. Santoiemma · 2015 · 342 citations · Cited by this paper
  10. Modulated calcium-sensing receptor (CaSR) expression in human breast cancer provided insights into tumor progression and therapeutic potential · 2026 · Related
  11. Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects · Paul W. Shafer · 2022 · 271 citations · Cited by this paper
  12. Global burden of multiple myeloma(1990–2021) and projections up to 2035: a methodical analysis leveraging the global burden of disease 2021 study and Mendelian randomization · 2026 · Related
  13. Drug resistance in ovarian cancer: from mechanism to clinical trial · Ling Wang · 2024 · 264 citations · Cited by this paper
  14. Overcoming barriers: mechanisms and strategies of nanoparticles in overcoming the blood-brain barrier and drug resistance in glioblastomas · 2026 · Related
  15. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells · Nuzhat Ahmed · 2018 · 182 citations · Cited by this paper
  16. The additive value of 3D automated breast ultrasound and contrast enhanced spectral mammography in the assessment of suspicious breast lesions · 2026 · Related
  17. Immune evasion by cancer stem cells · Hiroyuki Tsuchiya · 2021 · 149 citations · Cited by this paper
  18. Metabolic and nutritional impact of gastrectomy and perioperative treatment in gastric cancer: a prospective cohort study · 2026 · Related
  19. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements · Valéria Tavares · 2024 · 145 citations · Cited by this paper
  20. Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities · Anliang Xia · 2017 · 135 citations · Cited by this paper
  21. Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor–Engineered T Cells for Ovarian Cancer · Tatsuo Matsuda · 2018 · 82 citations · Cited by this paper
  22. CD4+ T-Cell Differentiation In Vitro · Wenyong Yang · 2020 · 73 citations · Cited by this paper
  23. Drug and apoptosis resistance in cancer stem cells (CSCs): A puzzle with many pieces · Ahmad R. Safa · 2022 · 64 citations · Cited by this paper
  24. Metabolic Plasticity in Ovarian Cancer Stem Cells · Alia Ghoneum · 2020 · 61 citations · Cited by this paper
  25. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma · Rodabe Navroze Amaria · 2024 · 56 citations · Cited by this paper
  26. Co-signaling receptors regulate T-cell plasticity and immune tolerance · Haitao Shen · 2018 · 44 citations · Cited by this paper
  27. Engineered Adoptive T-cell Therapy Prolongs Survival in a Preclinical Model of Advanced-Stage Ovarian Cancer · Kristin G. Anderson · 2019 · 40 citations · Cited by this paper
  28. CAR-T Cell Therapy in Ovarian Cancer: Where Are We Now? · Clare Cutri‐French · 2024 · 37 citations · Cited by this paper
  29. Genomic Characterization of High-Grade Serous Ovarian Cancer: Dissecting Its Molecular Heterogeneity as a Road Towards Effective Therapeutic Strategies · Lorenza Mittempergher · 2016 · 37 citations · Cited by this paper
  30. Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology · Andrzej Nowicki · 2021 · 30 citations · Cited by this paper
  31. Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy · Kristin G. Anderson · 2022 · 28 citations · Cited by this paper
  32. Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer · Thinle Chodon · 2018 · 17 citations · Cited by this paper
  33. A Nomogram Combining MRI Multisequence Radiomics and Clinical Factors for Predicting Recurrence of High-Grade Serous Ovarian Carcinoma · Cuiping Li · 2022 · 17 citations · Cited by this paper
  34. Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16 · Nicholas Paul Casey · 2024 · 17 citations · Cited by this paper
  35. Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma · Mengdi Fu · 2025 · 14 citations · Cited by this paper
  36. Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation · Thomas Kimman · 2025 · 14 citations · Cited by this paper
  37. Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment‐naïve patients: A single‐center study · Ilias P. Nikas · 2022 · 12 citations · Cited by this paper
  38. Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer · Wen‐Hung Chung · 2023 · 10 citations · Cited by this paper
  39. Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer · Jing Li · 2025 · 10 citations · Cited by this paper

Source: OpenAlex (CC0)